Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boceprevir Dose-Finding in HCV Genotype 1 Nonresponders
NCT00160251Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Sep 2005
- Primary completion
- Jul 2007
- Modality
- Orthosteric Ligands
01
Overview
A Phase 2 trial of boceprevir in hepatitis C (HCV), sponsored by Merck & Co.. Started Sep 2005; status: completed.
02
Drugs
boceprevir
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00160251.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00160251.